Intrathecal Therapy May Slow Fatal Niemann-Pick Disease Intrathecal Therapy May Slow Fatal Niemann-Pick Disease

Intrathecal hydroxyproyl-beta-cyclodextrin appears to slow progression of cognitive and speech deficits. Hearing loss was a notable adverse event but was ' manageable ' in this devastating disease, say investigators.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news